CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.

immunology virology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
23 Jul 2021
Historique:
received: 08 02 2021
revised: 26 03 2021
accepted: 08 06 2021
pubmed: 16 6 2021
medline: 16 6 2021
entrez: 15 6 2021
Statut: ppublish

Résumé

The identification of patients with coronavirus disease 2019 and high risk of severe disease is a challenge in routine care. We performed cell phenotypic, serum, and RNA sequencing gene expression analyses in severe hospitalized patients (n = 61). Relative to healthy donors, results showed abnormalities of 27 cell populations and an elevation of 42 cytokines, neutrophil chemo-attractants, and inflammatory components in patients. Supervised and unsupervised analyses revealed a high abundance of

Identifiants

pubmed: 34127958
doi: 10.1016/j.isci.2021.102711
pii: S2589-0042(21)00679-9
pmc: PMC8189740
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102711

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

None of the authors has any conflict of interest to declare.

Références

Am J Respir Crit Care Med. 2016 Oct 15;194(8):961-973
pubmed: 27064380
Mol Med Rep. 2017 May;15(5):2931-2939
pubmed: 28350095
Nat Methods. 2010 Apr;7(4):287-9
pubmed: 20208531
EMBO Rep. 2016 Oct;17(10):1374-1395
pubmed: 27629041
Blood. 2006 Jul 1;108(1):353-61
pubmed: 16543473
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7723-8
pubmed: 22550181
Crit Care Med. 1998 Nov;26(11):1793-800
pubmed: 9824069
Nat Med. 2020 Oct;26(10):1623-1635
pubmed: 32807934
Nat Med. 2020 Jul;26(7):1070-1076
pubmed: 32514174
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Nat Commun. 2019 Jul 31;10(1):3422
pubmed: 31366921
Proc Natl Acad Sci U S A. 1978 Mar;75(3):1121-5
pubmed: 274704
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Shock. 2016 Dec;46(6):672-680
pubmed: 27405064
Am J Pathol. 2011 Jul;179(1):199-210
pubmed: 21703402
Nat Microbiol. 2020 Nov;5(11):1361-1373
pubmed: 32690955
Science. 2017 Jun 9;356(6342):
pubmed: 28473638
Biosci Rep. 2020 Sep 30;40(9):
pubmed: 32808647
JAMA. 2020 Feb 25;323(8):709-710
pubmed: 31999307
Genome Med. 2021 Jan 13;13(1):7
pubmed: 33441124
J Clin Immunol. 2020 Nov;40(8):1082-1092
pubmed: 32829467
J Innate Immun. 2016;8(2):211-20
pubmed: 26756586
Immunol Lett. 2016 Oct;178:122-30
pubmed: 27568821
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Nat Commun. 2020 Jul 6;11(1):3434
pubmed: 32632085
BMJ. 2020 Jun 3;369:m2094
pubmed: 32493739
Cell. 2013 Jul 3;154(1):197-212
pubmed: 23827683
J Infect. 2020 Jul;81(1):e51-e60
pubmed: 32315725
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
Cytokine. 2020 Nov;135:155242
pubmed: 32799009
Inflamm Allergy Drug Targets. 2013 Dec;12(6):391-402
pubmed: 24090317
Thromb Res. 2020 Aug;192:3-8
pubmed: 32407937
Front Immunol. 2019 Apr 12;10:778
pubmed: 31031767
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
J Med Virol. 2021 Apr;93(4):2149-2159
pubmed: 33058220
Blood. 2012 Sep 6;120(10):2133-43
pubmed: 22837532
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Trends Immunol. 2003 Apr;24(4):155-8
pubmed: 12697438
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
PLoS Pathog. 2016 Oct 26;12(10):e1005982
pubmed: 27783669
Immunity. 2005 Jan;22(1):131-42
pubmed: 15664165
Nature. 1989 Jul 20;340(6230):239-41
pubmed: 2526925
J Immunol. 2010 Apr 1;184(7):3889-96
pubmed: 20194726
J Clin Invest. 2020 Oct 1;130(10):5223-5234
pubmed: 32644974
Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2
pubmed: 32407669
Nature. 2020 Aug;584(7821):463-469
pubmed: 32717743
Nature. 2019 Dec;576(7787):487-491
pubmed: 31827285
Cell. 2020 Sep 17;182(6):1419-1440.e23
pubmed: 32810438
Cell. 2020 Sep 17;182(6):1401-1418.e18
pubmed: 32810439
NAR Genom Bioinform. 2020 Nov 19;2(4):lqaa093
pubmed: 33575637
Sci Rep. 2019 Jan 23;9(1):328
pubmed: 30674924
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
JAMA. 2020 Oct 6;324(13):1292-1295
pubmed: 32876693
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Science. 2020 Aug 7;369(6504):643-650
pubmed: 32540902
Science. 2020 Sep 4;369(6508):1210-1220
pubmed: 32788292
Cell. 2020 Aug 20;182(4):828-842.e16
pubmed: 32645326
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Pediatr Rheumatol Online J. 2019 Jul 19;17(1):46
pubmed: 31324255
Cell Host Microbe. 2020 Jun 10;27(6):879-882.e2
pubmed: 32359396
Autoimmun Rev. 2020 Sep;19(9):102617
pubmed: 32663626
Crit Rev Clin Lab Sci. 2020 Sep;57(6):389-399
pubmed: 32503382
Immunology. 2017 Aug;151(4):375-384
pubmed: 28555812
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32302401
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Cell Host Microbe. 2009 Sep 17;6(3):207-17
pubmed: 19664979
Lancet. 2020 Jun 6;395(10239):1741-1743
pubmed: 32410759

Auteurs

Yves Lévy (Y)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.
Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert-Chenevier, Service Immunologie Clinique, Créteil, France.

Aurélie Wiedemann (A)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.

Boris P Hejblum (BP)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.
Univ. Bordeaux, Department of Public Health, INSERM U1219 Bordeaux Population Health Research Centre, Inria SISTM, UMR 1219, 146 Rue Leo Saignat, 33076 Bordeaux, France.

Mélany Durand (M)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.
Univ. Bordeaux, Department of Public Health, INSERM U1219 Bordeaux Population Health Research Centre, Inria SISTM, UMR 1219, 146 Rue Leo Saignat, 33076 Bordeaux, France.

Cécile Lefebvre (C)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.

Mathieu Surénaud (M)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.

Christine Lacabaratz (C)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.

Matthieu Perreau (M)

Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Emile Foucat (E)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.

Marie Déchenaud (M)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.

Pascaline Tisserand (P)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.

Fabiola Blengio (F)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.

Benjamin Hivert (B)

Univ. Bordeaux, Department of Public Health, INSERM U1219 Bordeaux Population Health Research Centre, Inria SISTM, UMR 1219, 146 Rue Leo Saignat, 33076 Bordeaux, France.

Marine Gauthier (M)

Univ. Bordeaux, Department of Public Health, INSERM U1219 Bordeaux Population Health Research Centre, Inria SISTM, UMR 1219, 146 Rue Leo Saignat, 33076 Bordeaux, France.

Minerva Cervantes-Gonzalez (M)

AP-HP, Hôpital Bichat, Département Épidémiologie Biostatistiques et Recherche Clinique, INSERM, Centre d'Investigation clinique-Epidémiologie Clinique 1425, F-75018 Paris, France.
AP-HP, Hôpital Bichat, Service de Maladies Infectieuses et Tropicales, F-75018 Paris, France.
Université de Paris, INSERM, IAME UMR 1137, F-75018 Paris, France.

Delphine Bachelet (D)

AP-HP, Hôpital Bichat, Département Épidémiologie Biostatistiques et Recherche Clinique, INSERM, Centre d'Investigation clinique-Epidémiologie Clinique 1425, F-75018 Paris, France.
Université de Paris, INSERM, IAME UMR 1137, F-75018 Paris, France.

Cédric Laouénan (C)

AP-HP, Hôpital Bichat, Département Épidémiologie Biostatistiques et Recherche Clinique, INSERM, Centre d'Investigation clinique-Epidémiologie Clinique 1425, F-75018 Paris, France.
Université de Paris, INSERM, IAME UMR 1137, F-75018 Paris, France.

Lila Bouadma (L)

APHP- Hôpital Bichat - Médecine Intensive et Réanimation des Maladies Infectieuses, Paris, France.

Jean-François Timsit (JF)

APHP- Hôpital Bichat - Médecine Intensive et Réanimation des Maladies Infectieuses, Paris, France.

Yazdan Yazdanpanah (Y)

AP-HP, Hôpital Bichat, Service de Maladies Infectieuses et Tropicales, F-75018 Paris, France.
Université de Paris, INSERM, IAME UMR 1137, F-75018 Paris, France.

Giuseppe Pantaleo (G)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.
Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Immunology and Allergy Service, Department of Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Hakim Hocini (H)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.

Rodolphe Thiébaut (R)

Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Hopital Henri Mondor, 51 Av Marechal de Lattre de Tassigny, 94010 Créteil, France.
Univ. Bordeaux, Department of Public Health, INSERM U1219 Bordeaux Population Health Research Centre, Inria SISTM, UMR 1219, 146 Rue Leo Saignat, 33076 Bordeaux, France.
CHU de Bordeaux, Pôle de Santé Publique, Service d'Information Médicale, Bordeaux, France.

Classifications MeSH